Andrew Long
Director/Board Member bij APRIA
Vermogen: 6 M $ op 29-02-2024
Profiel
Andrew G.
Long is CEO & Executive VP-Products & Healthcare Services at Owens & Minor, Inc. Mr. Long is also on the board of Apria, Inc.
In the past Mr. Long occupied the position of Chief Executive Officer & Director at INSYS Therapeutics, Inc. and Senior Vice President-Global Finance at Patheon, Inc.
He received an MBA from Kellogg School of Management and an undergraduate degree from Indiana University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
OWENS & MINOR, INC.
0.33% | 15-03-2024 | 249 780 ( 0.33% ) | 6 M $ | 29-02-2024 |
Actieve functies van Andrew Long
Bedrijven | Functie | Begin |
---|---|---|
OWENS & MINOR, INC. | Corporate Officer/Principal | 12-10-2022 |
APRIA | Director/Board Member | 29-03-2022 |
Eerdere bekende functies van Andrew Long
Bedrijven | Functie | Einde |
---|---|---|
INSYS THERAPEUTICS, INC. | Chief Executive Officer | 08-11-2019 |
PATHEON, INC. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Andrew Long
Indiana University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OWENS & MINOR, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
INSYS Therapeutics, Inc.
INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Apria, Inc.
Apria, Inc. Medical/Nursing ServicesHealth Services Apria, Inc. engages in the provision of healthcare services. The company was founded on March 22, 2018 and is headquartered in Indianapolis, IN. | Health Services |